Rankings
▼
Calendar
ELAN FY 2018 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena
ELAN
Elanco Animal Health Incorporated
$12B
FY 2018 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.1B
+6.2% YoY
Gross Profit
$1.3B
42.2% margin
Operating Income
$314M
10.2% margin
Net Income
$87M
2.8% margin
EPS (Diluted)
$0.28
Cash Flow
Operating Cash Flow
$487M
Free Cash Flow
$353M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$9.0B
Total Liabilities
$3.8B
Stockholders' Equity
$5.2B
Cash & Equivalents
$475M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.1B
$2.9B
+6.2%
Gross Profit
$1.3B
$1.2B
+10.4%
Operating Income
$314M
$142M
+120.4%
Net Income
$87M
-$311M
+127.8%
← Q4 2017
All Quarters
Q1 2018 →